ARTICLE | Company News
J&J gains option to ViaCyte's VC-01
August 22, 2014 12:28 AM UTC
ViaCyte Inc. (San Diego, Calif.) granted the Janssen Research & Development LLC unit of Johnson & Johnson (NYSE:JNJ) an option to license rights to VC-01, which is in development for Type I diabetes. ...